Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 21
Posts 3,304
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Navidea Biopharmaceuticals to Announce Second Quarter 2014 Financial Results on August 6, 2014 "Business Wire" - 7/29/2014 9:37:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2014 5:18:04 PM
Navidea Biopharmaceuticals Announces 2014 Annual Meeting Results "Business Wire" - 7/17/2014 3:44:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/16/2014 4:08:06 PM
Navidea Joins Essex Woodland’s Rheumco to Develop Radiopharmaceuticals for Detection and Treatment of Arthritic Diseases "Business Wire" - 7/16/2014 7:30:00 AM
Navidea Biopharmaceuticals to Present at the 9th Annual JMP Securities Healthcare Conference "Business Wire" - 6/17/2014 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2014 3:51:13 PM
U.S. FDA Approves Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection for Expanded Use in He... "Business Wire" - 6/13/2014 12:26:00 PM
Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation i... "Business Wire" - 6/11/2014 7:30:00 AM
Navidea Biopharmaceuticals Announces Positive Lymphoseek® (technetium Tc 99m tilmanocept) Injection Results on Injection Tim... "Business Wire" - 6/10/2014 4:30:00 PM
Navidea Announces Data Demonstrating Potential of Manocept™ Platform to Diagnose Rheumatoid Arthritis and Kaposi’s Sarcoma "Business Wire" - 6/10/2014 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/6/2014 10:38:45 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/6/2014 10:35:40 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/3/2014 2:18:30 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/2/2014 5:23:46 PM
Specialized Disclosure Report (sd) "Edgar (US Regulatory)" - 6/2/2014 2:26:38 PM
Navidea Biopharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference "Business Wire" - 5/29/2014 7:30:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/29/2014 6:00:46 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 5/23/2014 4:09:55 PM
Navidea Announces Eleven Scientific Presentations of Results from Lymphoseek® & Manocept™ Studies at the Society of Nuclea... "Business Wire" - 5/20/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2014 6:00:55 AM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 5/16/2014 9:47:18 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/15/2014 6:17:46 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/13/2014 5:29:14 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/9/2014 2:07:44 PM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 6795 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist